Amsterdam UMCs response to the European Commission's pharmaceutical legislation proposal centers on three crucial aspects: "Market Exclusivity," "Drug Repurposing," and "Hospital Exemption." We advocate for a recalibration of market exclusivity durations to foster competition, the active engagement of academia in drug repurposing, and the removal of constraints on ATMP manufacturing and delivery for improved patient…
AU
Amsterdam UMC
Academic / research · Netherlands
not in the EU Transparency RegisterThis organization files on consultations without a register number, so its record here is built from its filings alone. Register facts — staff, costs, accreditations — are not available for it.
2
positions filed
in the 583 files tracked
2
legislative files
of 583 tracked
1
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Track Amsterdam in PolicySpeak: request access →
Work at Amsterdam UMC? so we know who speaks for it.
Their record over time
Amsterdam UMC filed 2 positions between 18 May 2021 and 14 Sept 2023, across 2 of the 583 legislative files tracked here, attaching a full position paper 1 time.
2021 · 1 filed2023 · 1 filed
What they argued
Welcomes the fact that this will allow the manuals to be kept up to date, provided that the manufacturer/supplier stores them in a fixed digital place and is easily accessible to all parties (distributors and healthcare providers), as well as proper version management, so that customers can always have the latest version and quickly see the differences with older versions.
Filed in Dutch · English published by the European Commission
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Amsterdam UMC next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
Is this your organization?
Everything on this page comes from Amsterdam UMC’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.